Unmet Needs in R/R DLBCL
Dr Grzegorz S. Nowakowski muses on the unmet needs of patients with DLBCL and the emerging treatment options he looks forward to.
Considerations when Choosing a Second-Line DLBCL Treatment
An expert describes factors for consideration when choosing a second-line treatment for relapsed DLBCL.
Further-Line Treatment Options for Relapsed DLBCL
Grzegorz S. Nowakowski, MD, reviews the approved further-line treatment options for relapsed DLBCL.
Lenalidomide plus Tafasitamab for R/R DLBCL: The L-MIND Trial
An explanation of the design, efficacy, and adverse events of L-MIND, a trial investigating a combination treatment for R/R DLBCL.
Available Second-Line Treatments for Transplant-Ineligible R/R DLBCL
Dr Grzegorz S. Nowakowski reviews the currently available second-line treatment options for transplant-ineligible R/R DLBCL.
Risk Factors for Relapsed DLBCL
A discussion on the clinical factors that put patients at risk of having relapsed DLBCL.
Case Presentation: A 76-Year-Old Woman with DLBCL
Grzegorz S. Nowakowski, MD, presents the case of a woman with relapsed DLBLC and provides his initial impressions.
Unmet Needs Remain in the Diffuse Large B-Cell Lymphoma Treatment Paradigm
Grzegorz S. Nowakowski, MD, discusses the remaining unmet needs that exist in the treatment landscape of diffuse large B-cell lymphoma.